1-1 of 1
Tanja Schneider-Merck, PhD
Close
Sort by
Journal Articles

Recombinant Chimeric IgA1 and IgA2 Antibodies for Tumor Immunotherapy.

Michael Dechant, MD, Thomas Beyer, PhD, Stefan Lohse, Tanja Schneider-Merck, PhD, Wencke Weisner, Sven Berger, PhD, Matthias Peipp, PhD, Jan G.J. van de Winkel, PhD, Thomas Valerius, MD
Journal: Blood
Blood (2007) 110 (11): 4892.
https://doi.org/10.1182/blood.V110.11.4892.4892
Published: 2007